Skip to main content
. 2022 Dec 2;29(12):9452–9460. doi: 10.3390/curroncol29120743

Figure 2.

Figure 2

(a) PFS and (b) OS in patients with B3 thymoma and squamous carcinoma. PFS and OS did not differ between patients with B3 thymoma and squamous carcinoma (PFS, 11.3 vs. 11.7 months, p = 0.161; OS, 58.3 vs. 40.0 months, p = 0.114).